- PLN124.77m
- PLN151.42m
- PLN15.76m
Brief: Mabion Signs Framework Deal With UK Pharmaceutical Company
Brief: Mabion To Get 6.4 Mln Zloty Subsidy For Project
Brief: Mabion Q2 Net Profit At 10.3 Mln Zlotys
Brief: Mabion Signs Statement Of Work With UK-Based Company
Brief: Mabion Expands Collaboration With Novavax On Flu And COVID Vaccine Research
Brief: Mabion AGM To Vote On Allocating FY 2023 Net Profit For Coverage Of Losses
Brief: Mabion Q1 Net Profit Up At 17.5 Mln Zlotys
Brief: Mabion FY Net Profit Up At 41.3 Mln Zlotys
Brief: Mabion Prelim. FY Net Profit At 41.3 Mln Zlotys
Brief: Poland's Mabion Q3 Net Result Turns To Profit Of 10.9 Mln Zlotys
Brief: Mabion And Novavax Terminates Research Cooperation On SARS CoV-2 RS Wuhan Variant
Brief: Mabion Q2 Net Profit Up At 15.2 Mln Zlotys
Brief: Mabion Signs EUR 0.8 Mln Agreement With Bonfiglioli Engineering
Ryvu and TIM to enter Warsaw's mWIG40 index
Brief: Mabion Signs EUR 3.2 Mln Deal For Delivery Of Bioreactors
Brief: Poland's Mabion Q1 Net Profit Up At 16.5 Mln Zlotys
Brief: Mabion Reduces Number Of Bioreactors Under Deal With Adolf Kühner
Brief: Mabion Terminates Deal With Parexel International For MabionCD20 Clinical Trial
Brief: Mabion AGM To Vote On Retaining 2022 Net Profit